Chongqing Lummy Pharmaceutical Co., Ltd. Class A 300006
SZSE · China · Health Technology
CNY 5.56+0.26 (+4.91%)
Market closed· · CNY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · CNY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
MakklerAI · PRO
MakklerPRO is required for MakklerAI questions and forward scenarios grounded in structured data for the selected stock.
Upgrade to MakklerPROUpgrade to MakklerPRO to see the Makkler Fair Value calculation, the fundamental score and the multiples behind it.
Upgrade to MakklerPRO to see a 1-5 score for profitability, growth, cash-flow quality, and balance-sheet health.
Upgrade to MakklerPRO to see an AI-generated executive summary and bull/bear breakdown built from this stock's financial data.
| Company | Market cap | P/E | P/B | P/S | Net margin | Revenue growth | Dividend yield | Beta |
|---|---|---|---|---|---|---|---|---|
| 300006Chongqing Lummy Pharmaceutical Co., Ltd. Class A | CNY 5.87B |
| — |
| 3.4 |
| 7.5 |
| -17.0% |
| -5.8% |
| 0.0% |
| 1.3 |
| 300016Beijing Beilu Pharmaceutical Co., Ltd. Class A | CNY 5.69B | 37.8 | 2.2 | 4.2 | 11.0% | 18.3% | 0.6% | 1.0 |
| 000411Zhejiang Int'l Group Co., Ltd. Class A | CNY 5.66B | 12.2 | 1.0 | 0.2 | 1.3% | 2.5% | 3.5% | 0.7 |
| 600479Zhuzhou Qianjin Pharmaceutical Co., Ltd. Class A | CNY 6.10B | 17.1 | 2.0 | 1.6 | 9.1% | 6.1% | 3.1% | 0.9 |
| 600422KPC Pharmaceuticals, Inc. Class A | CNY 6.12B | — | 1.3 | 1.2 | -4.4% | -40.5% | 2.2% | 0.4 |
| 000915Shandong Wit Dyne Health Co., Ltd. Class A | CNY 5.58B | 13.3 | 2.1 | 2.9 | 22.1% | -10.8% | 10.5% | 0.8 |
| 002907Chongqing Pharscin Pharmaceutical Co., Ltd. Class A | CNY 6.20B | 83.9 | 3.6 | 7.7 | 9.4% | 0.0% | 0.5% | 0.5 |
| 300705Hunan Jiudian Pharmaceutical Co. Ltd. Class A | CNY 5.54B | 16.3 | 2.1 | 1.8 | 11.8% | -6.2% | 3.6% | 0.9 |
| 688566Jiangsu Jibeier Pharmaceutical Co. Ltd. Class A | CNY 5.52B | 25.9 | 2.2 | 5.6 | 21.1% | 9.0% | 1.9% | 1.2 |
| Peer median | 17.1 | 2.1 | 2.4 | 10.2% | 1.3% | 2.6% | 0.8 |
Peers are selected automatically from companies in the same industry. Extreme ratios (a loss-making company's P/E, or one distorted by a one-off item) are not adjusted away, which is why the summary row uses the median rather than the average. Not investment advice. The ratios in this table come from one outside provider for every company, so the comparison is internally consistent; they can differ from the filing-derived ratios higher up the page because the definitions differ.